Medications for Clostridioides Difficile

3 results

Rebyota (donor human stool)

(Donor Human Stool)
Ferring Pharmaceuticals Inc.
Usage: REBYOTA is indicated for preventing the recurrence of Clostridioides difficile infection (CDI) in adults 18 years and older after antibiotic treatment for recurrent CDI. It is not intended for treating CDI.
Akorn
Usage: Vancomycin hydrochloride capsules are indicated for treating Clostridioides difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including MRSA) in pediatric and adult patients under 18. It must be administered orally for these conditions, as parenteral use is ineffective.

Vowst (fecal microbiota spores, live-brpk)

(fecal microbiota spores, live-brpk)
Aimmune Therapeutics, Inc.
Usage: VOWST is indicated for the prevention of recurrent Clostridioides difficile infection (rCDI) in adults aged 18 and older after antibacterial treatment for rCDI. It is not intended for the treatment of CDI.